Source: Oncology and Therapy. Unidade: FM
Subjects: ESTUDOS RETROSPECTIVOS, LINFOMA, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DELAMAIN, Marcia Torresan et al. Long-term safety and effectiveness of Rituximab biosimilar RTXM83: a retrospective extension study in brazilian patients with diffuse large B-Cell lymphoma. Oncology and Therapy, v. 12, n. 3, p. 585-598, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/79464. Acesso em: 09 fev. 2026.APA
Delamain, M. T., Cardoso, A. C. F., Pericole, F. V., Araujo, S. S. da S., Fogliatto, L., Higashi, M., et al. (2024). Long-term safety and effectiveness of Rituximab biosimilar RTXM83: a retrospective extension study in brazilian patients with diffuse large B-Cell lymphoma. Oncology and Therapy, 12( 3), 585-598. doi:10.1007/s40487-024-00282-7NLM
Delamain MT, Cardoso ACF, Pericole FV, Araujo SS da S, Fogliatto L, Higashi M, Pereira J, Silva RL da, Werutsky G, Radtke P de PG. Long-term safety and effectiveness of Rituximab biosimilar RTXM83: a retrospective extension study in brazilian patients with diffuse large B-Cell lymphoma [Internet]. Oncology and Therapy. 2024 ; 12( 3): 585-598.[citado 2026 fev. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79464Vancouver
Delamain MT, Cardoso ACF, Pericole FV, Araujo SS da S, Fogliatto L, Higashi M, Pereira J, Silva RL da, Werutsky G, Radtke P de PG. Long-term safety and effectiveness of Rituximab biosimilar RTXM83: a retrospective extension study in brazilian patients with diffuse large B-Cell lymphoma [Internet]. Oncology and Therapy. 2024 ; 12( 3): 585-598.[citado 2026 fev. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79464
